NEO-811 Houston Site — Houston, Texas

NEO-811 Houston Site is a clinical research site located in Houston, Texas, United States 77054.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

NEO-811 Houston Site has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma, RCC.

Sponsors: Neomorph, Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEO-811 Houston Site?

NEO-811 Houston Site has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEO-811 Houston Site conducted?

NEO-811 Houston Site has 1 clinical trials on record, with 1 currently active. Their work covers Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma, RCC.

Is NEO-811 Houston Site accredited by Crixeo Health?

NEO-811 Houston Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEO-811 Houston Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.